Access to medications for opioid use disorder for formerly incarcerated individuals during community reentry: a mini narrative review

被引:2
|
作者
Chladek, Jason S. [1 ]
Chui, Michelle A. [1 ,2 ]
机构
[1] Univ Wisconsin Madison, Sch Pharm, Social & Adm Sci Div, Madison, WI 53706 USA
[2] Univ Wisconsin Madison, Sonderegger Res Ctr Improved Medicat Outcomes, Madison, WI USA
关键词
medication access; medications for opioid use disorder; opioid use disorder; formerly incarcerated; community reentry; transitions of care; METHADONE-MAINTENANCE; RELEASE; BUPRENORPHINE; PRISON; NALTREXONE; TRIAL;
D O I
10.3389/fpubh.2024.1377193
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Medications for opioid use disorder (MOUD) are especially important for formerly incarcerated individuals with opioid use disorder (OUD) and can reduce the risk of re-arrest and overdose during community reentry. Unfortunately, few formerly incarcerated individuals are able to access MOUD within the community, missing a critical tool for rehabilitation. A mini narrative review was conducted to highlight the published work that has been done to improve access to MOUD for formerly incarcerated individuals during reentry. The results yielded 15 records describing intervention evaluations, program descriptions, and research in progress. Most work is ongoing, showing promise that researchers have identified the importance of this problem. However additional research should be done to include other stakeholders and address the limitations of existing interventions and programs. Continued efforts can help ensure that formerly incarcerated individuals can safely and successfully reintegrate into society.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Medications for opioid use disorder in state prisons: Perspectives of formerly incarcerated persons
    Treitler, Peter C.
    Enich, Michael
    Reeves, Donald
    Crystal, Stephen
    SUBSTANCE ABUSE, 2022, 43 (01) : 964 - 971
  • [2] Medications for Opioid Use Disorder Among Incarcerated Individuals: a Review of the Literature and Focus on Patient Preference
    Puglisi, Lisa B.
    Bedell, Precious S.
    Steiner, Anna
    Wang, Emily A.
    CURRENT ADDICTION REPORTS, 2019, 6 (04) : 365 - 373
  • [3] Medications for Opioid Use Disorder Among Incarcerated Individuals: a Review of the Literature and Focus on Patient Preference
    Lisa B. Puglisi
    Precious S. Bedell
    Anna Steiner
    Emily A. Wang
    Current Addiction Reports, 2019, 6 : 365 - 373
  • [4] Benefits of COVID-19 viral screening of formerly incarcerated individuals during community reentry
    Quan, Nicolas G.
    Latif, Hassan
    Krsak, Martin
    Corbisiero, Michaele Francesco
    Solis, Jamie
    Wand, Taylor
    Mortaji, Parisa
    Vrolijk, Michael Aaron
    Kon, Shelley
    Ghandnoosh, Nazgol
    Franco-Paredes, Carlos
    THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2021, 8
  • [5] Barriers and facilitators to community pharmacist-provided injectable naltrexone for formerly incarcerated individuals during community reentry
    Chladek, Jason S.
    Chui, Michelle A.
    EXPLORATORY RESEARCH IN CLINICAL AND SOCIAL PHARMACY, 2025, 17
  • [6] Diversion of medications to treat opioid use disorder: Qualitative findings from formerly incarcerated adults in Massachusetts
    Evans, Elizabeth A.
    Pivovarova, Ekaterina
    Senthilkumar, Rithika
    Rottapel, Rebecca E.
    Stopka, Thomas J.
    Santelices, Claudia
    Ferguson, Warren J.
    Friedmann, Peter D.
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2023, 122
  • [7] Is Providing Medications for Opioid Use Disorder to Incarcerated Individuals a Cost-effective Strategy?
    Bounthavong, Mark
    JAMA NETWORK OPEN, 2023, 6 (04)
  • [8] Rapid Access to Medications for Opioid Use Disorder
    Kleinman, Robert A.
    Morris, Nathaniel P.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (11) : 3557 - 3558
  • [9] Rapid Access to Medications for Opioid Use Disorder
    Robert A. Kleinman
    Nathaniel P. Morris
    Journal of General Internal Medicine, 2021, 36 : 3557 - 3558
  • [10] Trends in Access to Medications for Opioid Use Disorder
    Gupta, Sumedha
    James, Aditya
    Miles, Jennifer
    Samples, Hillary
    Crystal, Stephen
    Simon, Kosali
    JAMA HEALTH FORUM, 2025, 6 (04):